Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots*

The dried blood spot (DBS) methodology provides a minimally invasive approach to sample collection and enables room-temperature storage for most analytes. DBS samples have successfully been analyzed by liquid chromatography multiple reaction monitoring mass spectrometry (LC/MRM-MS) to quantify a large range of small molecule biomarkers and drugs; however, this strategy has only recently been explored for MS-based proteomics applications. Here we report the development of a highly multiplexed MRM assay to quantify endogenous proteins in human DBS samples. This assay uses matching stable isotope-labeled standard peptides for precise, relative quantification, and standard curves to characterize the analytical performance. A total of 169 peptides, corresponding to 97 proteins, were quantified in the final assay with an average linear dynamic range of 207-fold and an average R2 value of 0.987. The total range of this assay spanned almost 5 orders of magnitude from serum albumin (P02768) at 18.0 mg/ml down to cholinesterase (P06276) at 190 ng/ml. The average intra-assay and inter-assay precision for 6 biological samples ranged from 6.1–7.5% CV and 9.5–11.0% CV, respectively. The majority of peptide targets were stable after 154 days at storage temperatures from −20 °C to 37 °C. Furthermore, protein concentration ratios between matching DBS and whole blood samples were largely constant (<20% CV) across six biological samples. This assay represents the highest multiplexing yet achieved for targeted protein quantification in DBS samples and is suitable for biomedical research applications.

[1]  Philip Brownridge,et al.  The importance of the digest: proteolysis and absolute quantification in proteomics. , 2011, Methods.

[2]  A. Johannessen.  Dried blood spots in HIV monitoring: applications in resource-limited settings. , 2010, Bioanalysis.

[3]  R. Dalton,et al.  Quantification of Hemoglobin A 2 by Tandem Mass Spectrometry , 2007 .

[4]  D. Tonoli,et al.  The use of mass spectrometry to analyze dried blood spots. , 2016, Mass spectrometry reviews.

[5]  Juncong Yang,et al.  MRM‐based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma , 2012, Proteomics.

[6]  Susan E. Abbatiello,et al.  Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach* , 2014, Molecular & Cellular Proteomics.

[7]  Christoph H Borchers,et al.  Enhanced sensitivity and multiplexing with 2D LC/MRM-MS and labeled standards for deeper and more comprehensive protein quantitation. , 2014, Journal of proteomics.

[8]  Andrew N Hoofnagle,et al.  Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. , 2012, Clinical chemistry.

[9]  V. Bours,et al.  Newborn screening for sickle cell disease using tandem mass spectrometry. , 2008, Clinical chemistry.

[10]  Yang Xu,et al.  Merck's perspective on the implementation of dried blood spot technology in clinical drug development - why, when and how. , 2013, Bioanalysis.

[11]  C. Libioulle,et al.  3-years experience review of neonatal screening for hemoglobin disorders using tandem mass spectrometry. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[12]  S. Lehmann,et al.  Current and future use of “dried blood spot” analyses in clinical chemistry , 2013, Clinical chemistry and laboratory medicine.

[13]  W. Lambert,et al.  Dried blood spots in toxicology: from the cradle to the grave? , 2012, Critical reviews in toxicology.

[14]  H. Rodriguez,et al.  Mass spectrometry‐based targeted quantitative proteomics: Achieving sensitive and reproducible detection of proteins , 2012, Proteomics.

[15]  Darryl B. Hardie,et al.  Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility. , 2014, Biochimica et biophysica acta.

[16]  Pei Wang,et al.  A targeted proteomics–based pipeline for verification of biomarkers in plasma , 2011, Nature Biotechnology.

[17]  Josephine Ec Burnett,et al.  Dried blood spot sampling: practical considerations and recommendation for use with preclinical studies. , 2011, Bioanalysis.

[18]  Pei Wang,et al.  Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins , 2013, Nature Methods.

[19]  D. Chace,et al.  Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. , 2003, Clinical chemistry.

[20]  Pieter MM De Kesel,et al.  Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions. , 2013, Bioanalysis.

[21]  L. Stolk,et al.  Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls , 2009, Therapeutic drug monitoring.

[22]  Christoph H Borchers,et al.  Method and platform standardization in MRM-based quantitative plasma proteomics. , 2013, Journal of proteomics.

[23]  S. Hillier,et al.  Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease. , 2014, Clinical chemistry.

[24]  B. Keevil.  The analysis of dried blood spot samples using liquid chromatography tandem mass spectrometry. , 2011, Clinical biochemistry.

[25]  Sharon Williams,et al.  What a drop can do: Dried blood spots as a minimally invasive method for integrating biomarkers into population-based research , 2007, Demography.

[26]  D. Eichner,et al.  Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport , 2013, Analytical and Bioanalytical Chemistry.

[27]  M. Rowland,et al.  Pharmacokinetic considerations as to when to use dried blood spot sampling. , 2010, Bioanalysis.

[28]  A. Ambekar,et al.  The Use of Dried Blood Spot Samples in Screening Drugs of Abuse , 2013 .

[29]  B. Güttler,et al.  Protein quantification by isotope dilution mass spectrometry of proteolytic fragments: cleavage rate and accuracy. , 2008, Analytical chemistry.

[30]  Darryl B. Hardie,et al.  Precise quantitation of 136 urinary proteins by LC/MRM-MS using stable isotope labeled peptides as internal standards for biomarker discovery and/or verification studies. , 2015, Methods.

[31]  Amanda G. Paulovich,et al.  An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers* , 2009, Molecular & Cellular Proteomics.

[32]  Michael J MacCoss,et al.  Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma* , 2015, Molecular & Cellular Proteomics.

[33]  H. Cooper,et al.  Challenges and opportunities in mass spectrometric analysis of proteins from dried blood spots , 2014, Expert review of proteomics.

[34]  P. Demirev.  Dried blood spots: analysis and applications. , 2013, Analytical chemistry.

[35]  J. Adamski,et al.  Targeted Metabolomics of Dried Blood Spot Extracts , 2013, Chromatographia.

[36]  J. Garin,et al.  Isotope dilution strategies for absolute quantitative proteomics. , 2009, Journal of proteomics.

[37]  D. Eichner,et al.  Sensitive quantification of IGF-1 and its synthetic analogs in dried blood spots. , 2014, Bioanalysis.

[38]  Yassene Mohammed,et al.  PeptidePicker: a scientific workflow with web interface for selecting appropriate peptides for targeted proteomics experiments. , 2014, Journal of proteomics.

[39]  M. Sadílek,et al.  Tryptic peptide analysis of ceruloplasmin in dried blood spots using liquid chromatography-tandem mass spectrometry: application to newborn screening. , 2008, Clinical chemistry.

[40]  R. Aebersold,et al.  Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions , 2012, Nature Methods.

[41]  Christoph H Borchers,et al.  Multiplexed MRM with Internal Standards for Cerebrospinal Fluid Candidate Protein Biomarker Quantitation. , 2014, Journal of proteome research.

[42]  Jeffrey R. Whiteaker,et al.  Anti-Peptide Monoclonal Antibodies Generated for Immuno-Multiple Reaction Monitoring-Mass Spectrometry Assays Have a High Probability of Supporting Western blot and ELISA* , 2014, Molecular & Cellular Proteomics.

[43]  Wenkui Li,et al.  Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. , 2010, Biomedical chromatography : BMC.

[44]  S. Carr,et al.  Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S , 2007, Molecular & Cellular Proteomics.

[45]  Christoph H Borchers,et al.  Multiplexed Quantitation of Endogenous Proteins in Dried Blood Spots by Multiple Reaction Monitoring - Mass Spectrometry , 2012, Molecular & Cellular Proteomics.

[46]  E. Swart,et al.  Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions , 2014, Clinical Pharmacokinetics.

[47]  W. Lambert,et al.  Current strategies for coping with the hematocrit problem in dried blood spot analysis. , 2014, Bioanalysis.

[48]  María Martín,et al.  UniProt: A hub for protein information , 2015 .

[49]  The Uniprot Consortium,et al.  UniProt: a hub for protein information , 2014, Nucleic Acids Res..

[50]  C. Greenberg,et al.  LC-MS/MS progress in newborn screening. , 2011, Clinical biochemistry.

[51]  N. Anderson,et al.  The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. , 2010, Clinical chemistry.

[52]  HighWire Press,et al.  Molecular & cellular proteomics , 2002 .

[53]  Ronald J. Moore,et al.  Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion. , 2013, Journal of proteome research.

[54]  Christoph H Borchers,et al.  Development of MRM-based assays for the absolute quantitation of plasma proteins. , 2013, Methods in molecular biology.

[55]  Richard D. Smith,et al.  Advancing the sensitivity of selected reaction monitoring‐based targeted quantitative proteomics , 2012, Proteomics.

[56]  Peter van Amsterdam,et al.  The application of dried blood spot sampling in global clinical trials. , 2010, Bioanalysis.

[57]  Yassene Mohammed,et al.  Qualis-SIS: automated standard curve generation and quality assessment for multiplexed targeted quantitative proteomic experiments with labeled standards. , 2015, Journal of proteome research.

[58]  Fumin Li,et al.  Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection. , 2012, Journal of mass spectrometry : JMS.

[59]  Christoph H Borchers,et al.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.

[60]  Chester L. Bowen,et al.  Investigations into the environmental conditions experienced during ambient sample transport: impact to dried blood spot sample shipments. , 2011, Bioanalysis.

[61]  T. McDade,et al.  A highly sensitive immunoassay for interleukin‐6 in dried blood spots , 2012, American journal of human biology : the official journal of the Human Biology Council.

[62]  A. Osterhaus,et al.  Current and future applications of dried blood spots in viral disease management. , 2012, Antiviral research.

[63]  R. Dalton,et al.  Quantification of hemoglobin A2 by tandem mass spectrometry. , 2007, Clinical chemistry.